Research Groups
Vaccine Development Group
The IBG Vaccine Development Group develops innovative vaccine and immunotherapeutic strategies against infectious diseases and immune disorders. The group conducts comprehensive R&D activities from design to clinical application, employing virus-like particles, smart nanocarriers, nucleic-acid–based immunomodulators, and next-generation adjuvants. Research efforts focus on developing new-generation vaccine solutions that provide long-term protection and demonstrate proven clinical efficacy.
